倍轻松公司及实控人被立案

Core Viewpoint - The company Beiqing Song faces regulatory scrutiny due to suspected information disclosure violations, leading to a significant drop in stock price and ongoing financial struggles [1][3]. Group 1: Company Overview - Beiqing Song, established in 2000, specializes in the design, research, development, production, sales, and service of smart portable health hardware, including various massage devices [1]. - The company went public on the Sci-Tech Innovation Board in July 2021 but has faced continuous financial pressure, reporting losses of 124 million yuan in 2022 and 50.87 million yuan in 2023, with a brief profit of 10.25 million yuan in 2024 [1]. Group 2: Financial Performance - In the first three quarters of the current year, Beiqing Song's performance deteriorated further, with both operating revenue and net profit attributable to shareholders declining year-on-year, resulting in losses exceeding 65 million yuan [1]. - The decline in revenue is attributed to a drop in online sales, while fixed expenses and rigid costs have not been adjusted accordingly [1]. Group 3: Marketing and R&D Issues - Beiqing Song has been criticized for prioritizing marketing over research and development, with advertising expenses consistently exceeding 50% of total sales costs [2]. - The company has a high sales personnel ratio of over 60%, significantly above the industry average of less than 24%, while the number of R&D staff has decreased, with only 11.86% of employees engaged in R&D as of mid-2025 [2]. Group 4: Quality and Service Complaints - The company's focus on light R&D has led to issues with product quality and after-sales service, resulting in numerous consumer complaints regarding product defects and poor service [2]. - Beiqing Song has faced legal challenges, including a lawsuit for patent infringement with a claim amount of 10 million yuan [2]. Group 5: Internal Governance and Financial Issues - Internal governance issues have been highlighted, with the company receiving regulatory inquiries regarding operational performance and allegations of irregular guarantees and fund misappropriation by the controlling shareholder, Ma Xuejun [3][4]. - Specific instances of fund misappropriation include loans from companies controlled by Ma Xuejun and early payments to suppliers that were redirected to his affiliates, totaling significant amounts from 2021 to 2024 [3]. Group 6: Regulatory Scrutiny and Responses - Beiqing Song has faced ongoing regulatory scrutiny, with the Shanghai Stock Exchange issuing inquiries about its financial management practices and internal controls [4][5]. - The company has acknowledged several irregularities and has taken corrective actions, including the disclosure of abnormal financial transactions and the sale of shares by Ma Xuejun, reducing his ownership stake [5].